ALGS
Price
$4.58
Change
-$0.47 (-9.31%)
Updated
May 6, 04:59 PM (EDT)
Capitalization
30.88M
XNCR
Price
$8.44
Change
-$2.28 (-21.27%)
Updated
May 6, 04:59 PM (EDT)
Capitalization
762.75M
2 days until earnings call
Ad is loading...

ALGS vs XNCR

Header iconALGS vs XNCR Comparison
Open Charts ALGS vs XNCRBanner chart's image
Aligos Therapeutics
Price$4.58
Change-$0.47 (-9.31%)
Volume$2.25K
Capitalization30.88M
Xencor
Price$8.44
Change-$2.28 (-21.27%)
Volume$226.53K
Capitalization762.75M
ALGS vs XNCR Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. XNCR commentary
May 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 06, 2025
Stock price -- (ALGS: $5.05 vs. XNCR: $10.72)
Brand notoriety: ALGS and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 103% vs. XNCR: 126%
Market capitalization -- ALGS: $30.88M vs. XNCR: $762.75M
ALGS [@Biotechnology] is valued at $30.88M. XNCR’s [@Biotechnology] market capitalization is $762.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а -4.72% price change this week, while XNCR (@Biotechnology) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.32%. For the same industry, the average monthly price growth was +9.19%, and the average quarterly price growth was -13.77%.

Reported Earning Dates

ALGS is expected to report earnings on Mar 10, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($763M) has a higher market cap than ALGS($30.9M). XNCR YTD gains are higher at: -53.351 vs. ALGS (-87.324). ALGS has higher annual earnings (EBITDA): -86.53M vs. XNCR (-186.17M). XNCR has more cash in the bank: 498M vs. ALGS (56.9M). ALGS has less debt than XNCR: ALGS (8.38M) vs XNCR (232M). XNCR has higher revenues than ALGS: XNCR (110M) vs ALGS (3.95M).
ALGSXNCRALGS / XNCR
Capitalization30.9M763M4%
EBITDA-86.53M-186.17M46%
Gain YTD-87.324-53.351164%
P/E RatioN/AN/A-
Revenue3.95M110M4%
Total Cash56.9M498M11%
Total Debt8.38M232M4%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 14 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 5 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PKSAX48.84N/A
N/A
Virtus KAR Small-Cap Core A
THCVX25.72N/A
N/A
Nuveen Large Cap Value Idx I
WESWX10.85N/A
N/A
TETON Westwood Equity AAA
BTMFX23.72N/A
N/A
Boston Trust Midcap
ARBNX13.73-0.02
-0.15%
Arbitrage I

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with STRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-9.82%
STRO - ALGS
39%
Loosely correlated
-4.55%
XNCR - ALGS
37%
Loosely correlated
-4.80%
RLAY - ALGS
34%
Loosely correlated
+2.15%
CRNX - ALGS
32%
Poorly correlated
-0.33%
TSHA - ALGS
30%
Poorly correlated
-4.65%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-4.80%
RCKT - XNCR
55%
Loosely correlated
-2.00%
ERAS - XNCR
53%
Loosely correlated
-8.23%
VCYT - XNCR
52%
Loosely correlated
+3.20%
CRNX - XNCR
52%
Loosely correlated
-0.33%
RLAY - XNCR
50%
Loosely correlated
+2.15%
More